Scientists at the University of California, Los Angeles (UCLA) have discovered a dendritic cell vaccine, CCL21-dendritic vaccine [29], which amplifies the immune system response to NSCLC. This evidence concerns the gene CCL21 and non-small cell lung carcinoma.